Covid-19 roundup: Pars­ing Bourla, a top an­a­lyst sees im­proved chances for Pfiz­er vac­cine; Fau­ci: No sur­prise that Trump was hit by Covid-19

With a med­ley of ad­verse events hob­bling the late-stage de­vel­op­ment of vac­cines and drugs, Pfiz­er CEO Al­bert Bourla’s lat­est — ex­tend­ed — time­line for the mR­NA ap­proach they’re work­ing on with BioN­Tech is giv­ing some top an­a­lysts added con­fi­dence that the phar­ma gi­ant can come up with the reg­u­la­to­ry goods next month.

Pars­ing Bourla’s lan­guage in his com­ments last week, SVB Leerink’s Ge­of­frey Porges notes that Bourla’s de­ci­sion to say they “may” be able to nail down the pos­i­tive ef­fi­ca­cy of their vac­cine in a mat­ter of days — a big change from his ear­li­er cer­tain­ty — may al­so in­di­cate a de­lay on that to ear­ly No­vem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER